New tests in gastroenterology
Transcript of New tests in gastroenterology
![Page 1: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/1.jpg)
New Tests in New Tests in GastroenterologyGastroenterology
Stephen Bridger
ACB Meeting 10/11/2005
![Page 2: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/2.jpg)
GastroenterologyGastroenterology
Too Busy– Too Many patients
IBS 14 - 24% of adult population, + 28% of referrals to GI clinics
– Too Many Investigations Doubling of endoscopy workload in last 10 yrs
Non Specific nature of GI symptoms Even alarm symptoms such as rectal bleeding common (1 in 7
adults/week) + poorly predictive of significant GI pathology
Unable to predict which of our chronic patients will relapse and when.
![Page 3: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/3.jpg)
“Would you mind very much if I went in before you? You’ve only a sore throat and I’ve diarrhoea”
![Page 4: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/4.jpg)
![Page 5: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/5.jpg)
Lundberg JO et al. (2005) Technology Insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease
Nat Clin Pract Gastroenterol Hepatol 2: 96–102 doi:10.1038/ncpgasthep0094
![Page 6: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/6.jpg)
CalprotectinCalprotectin
35 KDa Calcium and Zinc binding protein found in neutrophils, monocytes, and macrophages
Up to 60% of the total cytosolic protein content of neutrophils
First Described in 1980 Initially called L1 protein Antimicrobial and Anti-tumour activity reduces local zinc concentrations, and inhibits zinc
dependent metalloproteinases
![Page 7: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/7.jpg)
Clinical UseClinical Use
Resists metabolic degradation measured in stool, plasma, CSF, sputum, amniotic
fluid Stool samples can be sent by post, then frozen and
batch analysed Approx £10 per test Upper limit of normal in stool is 10mg/l As little as 5gm stool sample required
![Page 8: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/8.jpg)
Clinical UsesClinical Uses
extensively validated, showing consistent abnormalities in patients with IBD, colorectal carcinoma, and nonsteroidal enteropathy
Proposed as a useful outpatient screening test for organic small bowel or colorectal pathology. May be particularly useful in children.
Proposed as an IBD monitoring test, can predict steroid refractory disease, or which “well patients” are likely to relapse. Potential for monitoring the efficacy of new therapeutic regimes.
![Page 9: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/9.jpg)
General BackgroundGeneral Background
Levels relatively unaffected by GI bleeding need > 100mls of blood per day to increase
calprotectin level by 6mg/l In active Crohn’s disease, levels of calprotectin up
to 40,000 mg/l reported
![Page 10: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/10.jpg)
Guidelines for the investigation of
chronic diarrhoea, Gut 2003 “Stool markers of gastrointestinal
inflammation such as lactoferrin and, more recently, calprotectin, are of considerable research interest but, as yet, these have not
been introduced into clinical practice.”
![Page 11: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/11.jpg)
A simple method for assessing intestinal inflammation in Crohn's disease
Tibble et al Gut 2000
22 patients: fecal calprotectin compared with 4 day 111Indium White Cells– Good correlation (r = 0.8 , P<0.0001)
116 patients with known Crohn’s disease, calprotectin was compared with healthy controls
220 consecutive patients attending a GI clinic, 31 newly diagnosed Crohn’s disease, 159 patients with IBS...
![Page 12: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/12.jpg)
Calprotectin: Crohn’s versus Controls
![Page 13: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/13.jpg)
Calprotectin compared with CRP
![Page 14: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/14.jpg)
Use of surrogate markers of inflammation and Use of surrogate markers of inflammation and Rome criteria to distinguish organic from Rome criteria to distinguish organic from
nonorganic intestinal diseasenonorganic intestinal diseaseTibble et al Gastroenterology 2002Tibble et al Gastroenterology 2002
Prospective study: 602 new GI referrals 4 Gastroenterologists blinded to the results
of calprotectin and permeability, other investigations determined by Physicians
263 patients diagnosed with organic disease
![Page 15: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/15.jpg)
Referral SymptomsReferral Symptoms
![Page 16: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/16.jpg)
Calprotectin Levels in the Calprotectin Levels in the Different Diagnostic GroupsDifferent Diagnostic Groups
![Page 17: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/17.jpg)
Sensitivity/Specificity for Organic Sensitivity/Specificity for Organic and Non-Organic Diseaseand Non-Organic Disease
Sensitivity Specificity
Calprotecin >10mg/L
89 79
Positive RomeCriteria
85 71
CRP > 5.0 mg/L 50 81
ESR > 10mm/Hr
58 72
![Page 18: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/18.jpg)
Odds Ratios for Organic and Odds Ratios for Organic and Non-organic DiseaseNon-organic Disease
OR PPV NPV
Calprotecin >10mg/L
27.8(17.6 – 43.7)
0.76 0.89
CRP > 5mg/L 4.2(2.9 – 6.1)
.67 0.68
ESR >10mm/Hr
3.2(2.2 – 4.6)
0.62 0.69
L/R > 0.05 8.9(5.8 – 14)
0.56 0.89
+’ve RomeCriteria
13.3(8.9 – 20)
0.86 0.69
![Page 19: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/19.jpg)
Diagnostic accuracy of fecal calprotectin in Diagnostic accuracy of fecal calprotectin in distinguishing organic causes of chronic distinguishing organic causes of chronic
diarrhoea from IBS: A prospective study in diarrhoea from IBS: A prospective study in adults and children. adults and children.
Carroccio et al Clin Chem Jun 2003Carroccio et al Clin Chem Jun 2003
Prospective study 120 patients Raised Calprotecin levels predicted pts with
IBD with 100% sensitivity and 95% specificity Diagnostic accuracy higher in children Coeliac disease was the commonest cause of
false negatives
![Page 20: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/20.jpg)
Fecal calprotectin - a useful screening test for Fecal calprotectin - a useful screening test for inflammation of the colon in children.inflammation of the colon in children.
Fagerberg et al DDW 2003Fagerberg et al DDW 2003
36 children : calprotectin prior to colonoscopy
22 of the children had colitis on Hxpath + endoscopic criteria: – Mean calprotectin 349 (15.4 - 1860 mg/L)
Sensitivity & Positive predictive value 95% Specificity of 93%
![Page 21: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/21.jpg)
Fecal Calprotectin as an aid to Diagnosis in Fecal Calprotectin as an aid to Diagnosis in intestinal inflammationintestinal inflammation
Dolwani et al DDW 2003Dolwani et al DDW 2003
65 patients with abdo pain + diarrhoea All referred for Barium follow through 15 false negatives: 6 IBD, 4 IBS, 5
uncertain
Ba FT Normal Ba FT abnormal
Calprotectin < 60 33 1
Calprotectin > 60 15 16
![Page 22: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/22.jpg)
Fecal Calprotectin in steroid dependent Colitis. Fecal Calprotectin in steroid dependent Colitis. An indicator of clinical responseAn indicator of clinical response
Atkinson DDW 2003Atkinson DDW 2003 27 patients with steroid dependent colitis in remission Calprotectin checked at 0, 8 and 16 weeks steroids reduced at 2 weekly intervals until relapse or
cessation Mean Calprotectin at Time Zero was 6 x higher in
those patients who Relapsed (P = 0.0009) “CPT may differentiate between pts with merely symptomatic
response and those with genuine mucosal healing- failure to lower CPT sufficiently may indicate the need for a trial of a different therapy”
![Page 23: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/23.jpg)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with
inflammatory bowel disease Gastroenterology 2000;119:15-22
![Page 24: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/24.jpg)
Subclinical intestinal inflammation: An inherited abnormality in Crohn’s
disease relatives?Gastroenterology June 2003
![Page 25: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/25.jpg)
![Page 26: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/26.jpg)
Effect of Pentavac and MMR Effect of Pentavac and MMR vaccination on the intestinevaccination on the intestine
Gut 2002 816-17Gut 2002 816-17
109 consecutive infants attending an Iceland Vaccination clinic had fecal calpro taken 1 week prior and 2 and 4 weeks after Pentavac (12 months) and MMR (18 months)
No differences at any time of study “MMR very unlikely to cause ‘autistic
enterocolitis’”
![Page 27: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/27.jpg)
Calprotectin versus FOB in Bowel Calprotectin versus FOB in Bowel CancerCancer
FOB screening in asymptomatic patients has reduced bowel ca mortality by 15-33%
Detection threshold about 2-4 mls of blood/100g stool but tumours bleed intermittently and polyps may not bleed at all
Sensitivity of FOB may be as low as 26%
![Page 28: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/28.jpg)
Faecal Calprotectin and FOB tests in the Faecal Calprotectin and FOB tests in the diagnosis of colorectal carcinoma and diagnosis of colorectal carcinoma and
adenoma. Gut 2001 49(3):402-8adenoma. Gut 2001 49(3):402-8 3 FOBs and 1 stool calprotectin sample Three groups
– 96 Controls (healthy volunteers)– 62 consecutive patients with newly diagnosed
bowel cancer– 233 consecutive patients referred for
colonoscopy for polyp follow up, cancer surveillance, anaemia
![Page 29: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/29.jpg)
Calprotectin vs FOBCalprotectin vs FOB
Dukes Stage
n median range +’ve by calprotectin
+’ve by FOB
A 10 62.5 7-933 90 20B 24 115 2-3770 88 46C 14 62 1.5-
314 86 100
D 14 132 10.5 - 3388 100 71
![Page 30: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/30.jpg)
Faecal Calprotectin in the Different Faecal Calprotectin in the Different Diagnostic GroupsDiagnostic Groups
![Page 31: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/31.jpg)
Fecal Calprotectin levels in a high risk Fecal Calprotectin levels in a high risk population for colorectal neoplasia population for colorectal neoplasia
Kronberg et al Gut 2000 (46) 795 -800Kronberg et al Gut 2000 (46) 795 -800
![Page 32: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/32.jpg)
Calprotectin and CancerCalprotectin and Cancer
![Page 33: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/33.jpg)
ConclusionsConclusions
Calprotectin has significant advantages over guaiac based FOB testing– Higher sensitivity for colorectal ca – More likely to detect patients with Dukes A + B– More likely to detect patients with rectal and
right sided tumours– Single test rather than 3 samples– No dietary restrictions
![Page 34: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/34.jpg)
Conclusions 2Conclusions 2
Sensitivity >95% for detecting patients with IBD Failure to lower CPT predicts those patients with steroid
refractory disease (even if the patient has had a good symptomatic response to steroids)
Asymptomatic patients with IBD with CPT > 50mg/l have a 90% probability of relapse in the next 12 months
CPT reduction in IBD treated patients appears to correlate with endoscopic mucosal healing
CPT levels much more clinically useful in IBD than any of the currently used systemic immune tests (CRP, ESR, Igs, Plts)
![Page 35: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/35.jpg)
The Future?The Future?
GI OPD screening– Organic versus non-organic– Investigate versus observe
Population based bowel cancer screening– Selected high risk groups
IBD monitoring Availability ?
![Page 36: New tests in gastroenterology](https://reader035.fdocuments.in/reader035/viewer/2022062405/556e6f6dd8b42a795d8b479f/html5/thumbnails/36.jpg)